NeoPhore: Closes £6M Extension to Series B; Round to £21.5M
NeoPhore Closes £6M Extension to Series B; Round to £21.5MNeoPhore, a Cambridge, UK-based small molecule neoantigen immuno-oncology company, raised £6M in an extension...
© 2026 FintechInshorts. All Rights Reserved.

